Insights: Policy

Mergers & Acquisitions

DOJ Antitrust Leadership

In the wake of Assistant Attorney General Gail Slater, head of the DOJ’s Antitrust Division resigning, Omeed Assefi, previously Acting Assistant Attorney General before Slater’s confirmation, will serve as head of the Antitrust Division on an interim basis.

Endangerment Finding

Late last week, the Trump administration announced that it would be repealing the Endangerment Finding, an action it characterized as the “single largest deregulatory action in U.S. history.” The announcement also eliminated greenhouse gas (GHG) emission standards for all vehicles and engines of model years 2012 to 2027 and going forward. Should...

Energy, Financials, Healthcare, Housing, Infrastructure, Macro, Miscellaneous, Tech / Media / Telecom

State of the Union

President Trump will deliver his State of the Union (SOTU) speech next Tuesday, 2/24, and if precedent holds, is likely to issue his FY27 budget request by ~mid-March. The annual budget request provides a more granular overview of the administration’s policy priorities, and along with the speech, influences how the President’s allies in Congress...

340B Drug Discount Program

The White House Office of Management & Budget (OMB) is currently reviewing a proposed rule regarding the Health Resources and Services Administration’s (HRSA) 340B Rebate Pilot Program.

Democratic Drug Pricing Agenda

Democratic members of the Senate Finance Committee – including Ranking Member Wyden (D-OR) and Sens. Welch (D-VT), Cortez Masto (D-NV), and Gallego (D-AZ) – have released a high-level policy framework to lower drug prices.

ACA/PY27 Individual Market Regulations

The Centers for Medicare & Medicaid Services (CMS) issued the proposed “Notice of Benefit and Payment Parameters” for the plan year (PY) 2027. The rule sets standards for Affordable Care Act (ACA) coverage and the health insurance exchanges. Below is a high-level summary of the key attributes of the proposed rule that impact consumers, insurers,...